Depreciation of REVIVA PHARMACEUTICALS HOLDINGS, INC. from 31 Dec 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
REVIVA PHARMACEUTICALS HOLDINGS, INC. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2019 to 31 Mar 2024.
  • REVIVA PHARMACEUTICALS HOLDINGS, INC. Depreciation for the quarter ending 31 Mar 2024 was $0.
  • REVIVA PHARMACEUTICALS HOLDINGS, INC. annual Depreciation for 2021 was $0, a 100% decline from 2020.
  • REVIVA PHARMACEUTICALS HOLDINGS, INC. annual Depreciation for 2020 was $591, a 8.4% decline from 2019.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q1 2023 $0 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2020 $161 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1

REVIVA PHARMACEUTICALS HOLDINGS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2021 $0 -$591 -100% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2022 2021 FY
2020 $591 -$54 -8.4% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
2019 $645 01 Jan 2019 31 Dec 2019 10-K/A 07 May 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.